Education
About Us
Working with TipRanks
Follow Us
Torii Pharmaceutical Co Ltd (TRXPF)
OTHER OTC:TRXPF
Total Valuation
Torii Pharmaceutical Co has a market cap or net worth of $1.22B. The enterprise value is $42.70B.
Market Cap$1.22B
Enterprise Value$42.70B
Share Statistics
Torii Pharmaceutical Co has 28,800,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding28,800,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Torii Pharmaceutical Co’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 4.16%.
Return on Equity (ROE)0.04
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)4.16%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee102.07M
Profits Per Employee8.52M
Employee Count592
Asset Turnover0.43
Inventory Turnover2.53
Valuation Ratios
The current PE Ratio of Torii Pharmaceutical Co is 26.29. Torii Pharmaceutical Co’s PEG ratio is 1.23.
PE Ratio26.29
PS Ratio0.00
PB Ratio0.69
Price to Fair Value1.09
Price to FCF38.28
Price to Operating Cash Flow33.83
PEG Ratio1.23
Income Statement
In the last 12 months, Torii Pharmaceutical Co had revenue of 60.43B and earned 5.04B in profits. Earnings per share was 179.37.
Revenue60.43B
Gross Profit24.42B
Operating Income6.80B
Pretax Income6.72B
Net Income5.04B
EBITDA7.21B
Earnings Per Share (EPS)179.37
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Torii Pharmaceutical Co pays an annual dividend of $0.421, resulting in a dividend yield of 2.3%
Dividend Per Share$0.421
Dividend Yield2.3%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.41
52-Week Price Change62.76%
50-Day Moving Average34.72
200-Day Moving Average30.59
Relative Strength Index (RSI)76.47
Average Volume (3m)0.00
Important Dates
Torii Pharmaceutical Co upcoming earnings date is Jul 31, 2025, TBA Not Confirmed.
Last Earnings DateApr 25, 2025
Next Earnings DateJul 31, 2025
Ex-Dividend DateJun 27, 2025
Financial Position
Torii Pharmaceutical Co as a current ratio of 5.21, with Debt / Equity ratio of 0.44%
Current Ratio5.21
Quick Ratio4.43
Debt to Market Cap0.00
Net Debt to EBITDA-0.40
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Torii Pharmaceutical Co has paid 1.68B in taxes.
Income Tax1.68B
Effective Tax Rate0.25
Enterprise Valuation
Torii Pharmaceutical Co EV to EBITDA ratio is 17.99, with an EV/FCF ratio of 37.18.
EV to Sales2.15
EV to EBITDA17.99
EV to Free Cash Flow37.18
EV to Operating Cash Flow35.63
Balance Sheet
Torii Pharmaceutical Co has $43.30B in cash and marketable securities with ¥429.00M in debt, giving a net cash position of -$42.87B billion.
Cash & Marketable Securities$43.30B
Total Debt¥429.00M
Net Cash-$42.87B
Net Cash Per Share-$1.49K
Tangible Book Value Per Share$4.31K
Margins
Gross margin is 47.81%, with operating margin of 11.25%, and net profit margin of 8.34%.
Gross Margin47.81%
Operating Margin11.25%
Pretax Margin11.13%
Net Profit Margin8.34%
EBITDA Margin11.93%
EBIT Margin11.25%
Analyst Forecast
The average price target for Torii Pharmaceutical Co is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―